GLOBUS MEDICAL INC - A (GMED) Stock Price & Overview
NYSE:GMED • US3795772082
Current stock price
The current stock price of GMED is 86.25 USD. Today GMED is down by -1.1%. In the past month the price decreased by -6.13%. In the past year, price increased by 18.88%.
GMED Key Statistics
- Market Cap
- 11.665B
- P/E
- 21.56
- Fwd P/E
- 19.09
- EPS (TTM)
- 4.00
- Dividend Yield
- N/A
GMED Stock Performance
GMED Stock Chart
GMED Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to GMED. When comparing the yearly performance of all stocks, GMED turns out to be only a medium performer in the overall market: it outperformed 68.04% of all stocks.
GMED Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to GMED. Both the health and profitability get an excellent rating, making GMED a very profitable company, without any liquidiy or solvency issues.
GMED Earnings
On February 24, 2026 GMED reported an EPS of 1.28 and a revenue of 826.42M. The company beat EPS expectations (9.18% surprise) and beat revenue expectations (1.39% surprise).
GMED Forecast & Estimates
22 analysts have analysed GMED and the average price target is 107.03 USD. This implies a price increase of 24.09% is expected in the next year compared to the current price of 86.25.
For the next year, analysts expect an EPS growth of 12.98% and a revenue growth 9.89% for GMED
GMED Groups
Sector & Classification
GMED Financial Highlights
Over the last trailing twelve months GMED reported a non-GAAP Earnings per Share(EPS) of 4. The EPS increased by 27.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.3% | ||
| ROA | 10.14% | ||
| ROE | 11.76% | ||
| Debt/Equity | 0 |
GMED Ownership
GMED Latest News, Press Relases and Analysis
GMED Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.12 | 182.195B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.17 | 169.785B | ||
| SYK | STRYKER CORP | 21.72 | 127.279B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.49 | 103.19B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.11 | 47.637B | ||
| IDXX | IDEXX LABORATORIES INC | 38.47 | 46.061B | ||
| BDX | BECTON DICKINSON AND CO | 11.44 | 44.485B | ||
| RMD | RESMED INC | 18.58 | 33.211B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.73 | 32.655B | ||
| DXCM | DEXCOM INC | 26.2 | 25.378B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.18 | 17.178B | ||
| HOLX | HOLOGIC INC | 15.39 | 16.886B | ||
| PODD | INSULET CORP | 34.88 | 15.986B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GMED
Company Profile
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Company Info
IPO: 2012-03-08
GLOBUS MEDICAL INC - A
2560 General Armistead Ave
Audubon PENNSYLVANIA 19403 US
CEO: David M. Demski
Employees: 5300
Phone: 16109301800
GLOBUS MEDICAL INC - A / GMED FAQ
What does GLOBUS MEDICAL INC - A do?
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Can you provide the latest stock price for GLOBUS MEDICAL INC - A?
The current stock price of GMED is 86.25 USD. The price decreased by -1.1% in the last trading session.
What is the dividend status of GLOBUS MEDICAL INC - A?
GMED does not pay a dividend.
What is the ChartMill technical and fundamental rating of GMED stock?
GMED has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What do analysts say about GLOBUS MEDICAL INC - A (GMED) stock?
22 analysts have analysed GMED and the average price target is 107.03 USD. This implies a price increase of 24.09% is expected in the next year compared to the current price of 86.25.
Is GLOBUS MEDICAL INC - A (GMED) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GMED.
How many employees does GLOBUS MEDICAL INC - A have?
GLOBUS MEDICAL INC - A (GMED) currently has 5300 employees.